Developmental Trauma (DT) or complex childhood trauma is arguably one of the most important public health challenges in the United States. It has a negative impact on the mental, physiological and neurobiological functioning, leads to a lower quality of life, early death and creates a substantial financial burden for the individuals affected, their families, and the healthcare system as a whole. Moreover, people with DT are often more resistant to traditional therapy. Research have shown that neurofeedback and biofeedback effectively treat people with DT. The purpose of this workshop is to deepen the participantsду» understanding of DT and ways to effectively incorporate neurofeedback and biofeedback to treat individuals with DT. The workshop will address an integrative approach to Treat Developmental Trauma Using Neurofeedback and Biofeedback. It will begin by ways to detect DT and how it differs from PTSD. After providing an overview of the impact of DT on health and well-being it will focus on the brain development and functioning. Next, the workshop will review research on the effectiveness of neurofeedback and biofeedback on individuals with DT. Finally, it will focus on the challenges therapists may encounter when working with individuals with DT, and ways to integrate traditional therapy with neurofeedback and biofeedback in overcoming those challenges. Case presentation will be used to highlight these points. The second part of the workshop will focus on the importance of incorporating neurological and physiological assessments. i.e. neuromarkers and physiomarkers, in addition to the traditional subjective assessments (e.g. questionnaires). At the individual level, we will discuss ways of assessing clientsду» baseline functioning, providing guidance for treatment, and tracking progress. To further the use and improve the outcome of these techniques, the benefits and challenges of identifying patterns of brain and physiological activities will be discussed. Overall, this workshop will provide its participants with a more complete understanding of DT and ways to improve treatment outcomes through at integrative approach. The workshop will be concluded with future directions and challenges.

Neurotherapy is rapidly evolving into a primary care option for many disorders. Problems with mood, anxiety, sleep quality, learning, cognitive processing, pain, addictions, anger management, and age-related memory are all amenable to rapid assessment and treatment. The assessment procedures are simple and straight forward involving assessment of a limited number of brain sites. Treatment options other than neurofeedback have been developed to markedly accelerate neurotherapy. Primary among these treatment options is the braindriving procedure. These complementary techniques markedly facilitate neurotherapy as a viable primary care alternative to dangerous and often ineffective pharmaceuticals. The workshop starts with the precise ClinicalQ assessment procedure that determines treatment strategies. The ClinicalQ data base contains over 1500 clinical patients and has proven to be far more accurate as compared with data bases based on presumptively думnormalдуќ subjects. Emphasis is on Braindriving treatment procedures, including review of major unconditioned stimuli required for treatment. Other treatment options including neurofeedback, AVS, CES, energy psychology methods, craniosacral manipulations, harmonic sounds, electrostimulation, and behavior therapies appropriate for a wide range of disorders are presented. Practitioners will be able to immediately apply these efficient techniques. Conditions that require full QEEG and normative data base procedures will be identified, as will conditions in which the more aggressive treatments are contraindicated. Materials provided will include detailed procedures for the rapid assessment protocol, including the listing of therapeutic probes associated with irregular activity at all recording sites. Also included in the provided materials include site location forms for acupuncture meridians, parameters associated with developing unconditioned stimuli for the Braindriving (classical conditioning) paradigms and procedure sheets for energy routines. Hands-on training for some craniosacral manipulations, acustimulation and energy routines is provided. This workshop is presented in response to many requests from previous participants in shorter workshops for one full day of training in these effective neurotherapeutic techniques.

This 3-day workshop provides a deeper learning opportunity for the LENS Provider, which includes concepts of the LENS and itsН application, supporting paradigms, advanced principles, and expanded areas of applicability to include complex patient presentations in the use of the Low Energy Neurofeedback System (LENS). How to more deeply integrate the concepts into the practitionerНs practice, with special emphasis on complex case presentations and symptom constellations. The workshop will offer hands-on training in the more advanced use and application of the LENS. Day 3: Concepts, principles, and areas of applicability for BodyLENSTM. Maximization of BodyLENSTM effects. Participants will be introduced to the BodyLENSTM software. Features of the BodyLENSTM software will be covered: electrode placement, dosage, 2 Channel use. A first session will be practiced by participants on each other. 2 Channel LENS concepts will be presented. Maximizing the effect of 2 Channel LENS with complex clients will be discussed.

The 3-dimensional evaluation of the sources of non-ictal discharges and focal gross pathologies has recently been enhanced using advanced technology called swLORETA (weighted sLORETA (Palmero-Soler et al, 2007). swLORETA uses Single-Value-Decomposition (SVD) to weight the lead field in order to increase lead field homogeneity and hence improved localization of deep sources. This allows for estimates of EEG sources in different layers of the cortex. Also, swLORETA uses a real MRI and not an average MRI with 12,270 voxels and a Boundary-Element-Method (BEM) of source localization (Wroel and Aliahadi, 2002). Non-ictal events and gross pathologies are localized inside of 3дуђdimensional volumes with the aid of slice and volume cutting tools to allow one to navigate through the brain and identify dysregulated brain network hubs (Brodmann areas) and connections. Computations include Functional Connectivity (Coherence, Lagged Coherence and Phase Difference) and Effective Connectivity (Phase Slope Index) of the magnitude and direction of information flow between network hubs as well as integration with Diffusion Tensor Imaging (DTI). A useful method is to also view the EEG potentials on a transparent scalp while simultaneously viewing the deeper sources of the EEG from inside the brain. Both raw scores and Z scores are used as well as the Laplacian transform of the scalp EEG. Examples of source localization in patients with gross pathologies such as epileptic foci, TBI and stroke will be presented. Also, how to create a Neurofeedback protocol designed to target dysregulated brain networks linked to symptoms will be demonstrated. Understanding cross-frequency coupling from brainstem to limbic system to cortex including Neurofeedback protocol generation. Cross-frequency measures such as cross-frequency phase-amplitude coupling, cross-frequency coherence, cross-frequency power and cross-frequency phase reset will be demonstrated. Advanced Neuroimaging topics will be covered including the potential to resolve sources in the Thalamus, Sub-Thalamus, Habenua and Cerebellum. Implications and future applications of Neurofeedback including Cerebellar Neurofeedback will be discussed.

The brain responds extremely well to stimulation. Since the discovery of photic driving by Adrian and Matthews in 1934, much has been discovered about the benefits of brainwave entrainment (BWE) or audio-visual entrainment (AVE), as it is commonly known today. AVE increases cerebral blood flow, beneficial neurotransmitters, has profound calming effects, induces a meditative mind state, increases brain lactate, triggers heat-shock protective protein and excites micro-glia. Research on the effectiveness of AVE in promoting relaxation, cognition and hypnotic induction, treating ADD, PMS, SAD, PTSD, migraine headache, chronic pain, anxiety, depression and episodic memory is now available. Recent discoveries have shown AVE to be a powerful means of recovery from traumatic brain injuries of a newly discovered type, termed thalamocortical disconnect. Cranio-electro stimulation (CES) is the application of a small current across the cranium. CES has been used over several regions of the brain, but itду»s primary focus is for stimulation of the brain stem. CES was initiated by Robinovitch, who, in 1914, made the first claim for electrical treatment of insomnia. In 1958, the book Electro-Sleep inspired research in Europe and in Eastern Block countries, as well as in South America, Asia and finally the US. Most of the roughly 200 studies have shown CES as a reliable method for drug rehab, for reducing anxiety, depression, pain, improving sleep, plus improve cognition and IQ. Roughly 1/3 of people donду»t respond to CES, while another third show mild to moderate improvement. However, some people respond exceptionally well. I have been recording EEG and processing the qEEGs of my best CES responders. These data will be presented. Transcranial DC Stimulation (tDCS) has been extensively studied since the 1980s, totalling roughly 1200 studies to date. A major advantage of tDCS is that it may be applied directly over an area of concern where the cortical activity over a specific site on the brain may be enhanced or suppressed, much like neurofeedback. Pretty much every possible aspect of human function has been studied with tDCS. tDCS works well for boosting peak mental performance in a wide variety of areas, the treatment of depression and a myriad of cognitive concerns, especially challenges resulting from stroke. Over 300 studies using tDCS for stroke rehabilitation (ataxia, apraxias and aphasias) have been published to date. The physiological principles of tDCS will be explained as well as clinical outcomes.

Over 99% of American businesses are categorized as small businesses дус those employing less than 100 persons дус and small businesses employ 48% of working Americans (McIntyre, 2018 , Desjardins, 2017). Although there is dispute of exactly how many small businesses fail дус between 33% and 46% in the first 5 years, and nearly 80% failing by year 10 дус there is general consensus as to why they fail (McIntyre, 2018 , Desjardins, 2017 , Waring, 2017). Reasons for failure range from no market for the service, poor cash flow, poor team chemistry/bad hires, being out-competed, pricing/cost concerns, loss of focus, burnout, and poor marketing, among others (Wagner, 2012 , Gerber, 1995, 2005). These areas of failure are attributable to what Gerber (1995, 2005) says are the failures in, and competing requirements of, the three roles the small business owner fills: the entrepreneur, the technician, and the manager. For neurofeedback professionals, and others in the brain/mental health care space, nothing in the formal curriculum of licensure track graduate schools prepares them for building and growing a practice that will survive long term. Many of the obstacles to growth faced by neurofeedback professionals are common to all small business owners and are the result of limiting beliefs, faulty assumptions (Hyatt, 2018), and failing to work on the business due to the time demands of working in the business (Gerber, 2005 , Pagan, 2018). Others make the mistake of engaging in "hope marketing" (Walker, 2014), the idea that "if you build it, they will come." Neurofeeback practices, like other small businesses, have basic business activities (marketing, sales, delivery) and disciplines (brand, finance, management) that require the entrepreneur's disciplined leadership if the business is to succeed (Gerber, 1995, 2005). The nature of neurofeedback encourages the neurofeedback professional to cling to the technician role, often to the neglect of the entrepreneur role. The technician is the worst marketer, often focusing on the technology and not the transformation that neurofeedback offers to clients. The entrepreneur however, can tell a compelling story, the hero's journey, that connects with their vision and passion that will resonate with prospective clients. Neurofeedback professionals, as other entrepreneurs, struggle with identifying ideal clients (avatars) and appropriate marketing tools and strategies, and using social media as a means of engaging existing and potential clients (Brunson, 2017 , Walker, 2014). However, growth opportunities afforded by mastermind communities, referral source connection events, technology, customer relations management (CRM) tools, and social media marketing abound for entrepreneurs willing to be stretched personally and professionally (Brunson, 2017 , Patel, 2017 , Pagan, 2018).

This beginners level, Infraslow Fluctuation Training will demonstrate this unique neurofeedback process in clinical practice in a three day workshop. The method pivots on the determination of an optimum frequency (OF) that is discovered for each client. Day one is the didactic portion of the workshop that includes basic software instruction, experiential training in a clinical decision tree for defining beginning placements, a demonstration of the OF determination process along with a discussion of the equipment and optimal signal processing requirements necessary to accomplish effective training. The value of QEEG in predicting treatment responders, treatment planning, and determining treatment outcomes will be established. Day two and three will be hands-on instruction in ISF training. Students will have several opportunities to implement and experience ISF training. Infraslow frequencies were first identified by Russian researchers in the 1950s (Aladjalova, 1957, 1964). These slow processes have been associated with the Hypothalmic Pituitary Adrenal Axis since that time when Aladjalova implanted electrodes in rabbit Hypothalamus. She described an increase in amplitude and a decrease in frequency in response to wounding that she theorized was a reparative, parasympathetic response. Infraslow frequencies, also corroborated by Joe Kamiya (Girton, Benson, & Kamiya, 1973), have become a signal of significant interest to researchers recently. Research suggests that the infraslow signal underlies the excitability dynamics of cortical networks (Vanhatalo et al., 2004). Vanhatalo, convinced of ISF's centrality in cortex, stated that any attempt to attenuate this slow signal eliminates the most salient features of the human EEG. Further, it appears to be a direct electrophysiological correlate for slow fluctuations in human psychophysical performance (Monto, Palva, Voipio, & Palva, 2008). Most recently research has suggested that very slow oscillations are associated with the Default Mode Network of the human cerebral cortex and appear to be related to ADHD symptom status (Broyd, Helps, & Sonuga-Barke, 2011 , Tye et al., 2012). Palva (Palva & Palva, 2012) describes the Infralsow frequencies as the думsuperstructureдуќ in cortex that regulates the activity within and between active neuronal networks. A recent software innovation has allowed this slow signal to be simultaneously rendered in a bipolar and referential montage. The advancement has made it possible to record in two channels while training on the bipolar montage. This allows for the monitoring of Zscores, slow cortical potentials, and raw amplitudes at each site during ISF training. This improvement makes for a safe, effective, and data rich method of slow wave training. This workshop will be taught on the Brainmaster Avatar platform that utilizes the Atlantis or Discovery amplifier. Attendees with equipment should contact admin@neurofeeedbackservicesny.com to arrange for an ISF license before the workshop. Attendees do not need to have a Discovery, an Atlantis, the Avatar software, or an ISF License to attend. There will be enough equipment and software available for all attendees to use in the workshop. However, for the best learning experience it is recommended that attendees obtain either the Atlantis or the Discovery amplifier, and the Avatar Software with an ISF License.

This 3-day workshop is a learning arena for the practitioner, which includes essential concepts, core paradigms, principles, and areas of applicability of the Low Energy Neurofeedback System (LENS), and how to integrate the concepts into the practitionerНs practice. The workshop will offer hands-on training in the LENS in addition to a foundational knowledge in assessing the client, development of a treatment plan, using the concepts presented and how to reevaluate the effectiveness of the treatment plan. Day 3: Discussion of when, why and how to adjust the treatment plan based upon patient response to the previous session. Presentation of how altering the various application settings impact the course of treatment. Discussion of medication effects on client symptom profile, what to monitor and when adjustment might be necessary. ______________

The neurotherapist is first a neuroscientist, a neurophysiologist, a neuroanatomist. Mastering these areas is a necessity before applying modalities such as neurofeedback, magnetic stimulation and electrical stimulation. Furthermore, the neurotherapist increasingly has the opportunity to interact and share clients with neurologists. The goal of this workshop is to provide the framework of clinical neurophysiology and functional neuroanatomy for a spectrum of the more common disorders that affect the nervous system. Presented by a neurologist/clinical neurophysiologist, and his chief EEG/neurotherapy technologist, this workshop will build a common bridge for communication between the fields of neurotherapy and neurology. The workshop begins with a review of functional neuroanatomy. Structural and physiologic correlates to brain, spinal cord, and peripheral nervous system function will be reviewed. Fundamentals of the tools that have been historically used to define these functions, such as EEG, QEEG, MRI, PET, SPECT, cognitive and event related evoked potentials will be discussed. The workshop will then review a variety of common disorders that affect the nervous system including QEEG findings and neurotherapy strategies for each: Seizure disorders are common disorders which affect the brain and often present with abnormalities of the EEG/QEEG. The current nomenclature and organizational understanding of the various seizure types will be reviewed. Appearance of various paroxysmal disturbances seen on EEG will be presented. Standard medication and non-medication therapies, including neurofeedback will be discussed. Concussion/Traumatic Brain Injury are perhaps one of the most common presenting disorders affecting brain function. A review of the acute and chronic pathophysiology along with neuroimaging, EEG and QEEG findings commonly associated with these injuries, epidemiology, and clinical management will be presented. Sleep disorders are common confounding variables to neurotherapy. Often treatment of the underlying sleep problems will affect the QEEG appearance. Similarly, neurotherapy often will result in improved sleep quality. The workshop will review common sleep disorders including insomnia, sleep apnea, restless legs and periodic limb movements, shift work and other circadian disorders, and narcolepsy. Migraine is another common physiologic disorder affecting 1 out every 5 women. The neurovascular theory of migraine pathophysiology will be presented. Migraine may have a complex presentation including complicated aura, and associated symptoms such as sensory sensitivity, nausea and pain. Pharmacologic, nutritional supplement, and neurotherapy strategies will be reviewed. Stroke and Neurodegenerative disorders. These are the common disorders of the elderly. The anatomy of the vascular supply to the brain will be reviewed. Common and rare causes of stroke will be presented. Prevention and treatment strategies will be discussed. A review of the neurodegenerative disorders including Alzheimerду»s, Parkinsonду»s, Lewey Body Disease, Multiple System Atrophy, and others will be presented as well. Toxic/Metabolic Encephalopathies. The common causes for toxic and metabolic encephalopathies including thyroid disease, hypoxia, hypercarbia, hepatic and renal failure and others and their effects on the QEEG will be presented. Attention Deficit Disorder. A neurological historical perspective of the disorder will be presented. Current concepts, epidemiology, natural longitudinal progression, and treatments will be reviewed. The workshop will end with a Q&A discussion to review the days topics.

This course satisfies 24 of the 36 didactic course requirements for QEEG Certification as arranged by the QEEG Certification Board. Attendees will earn up to 24 hours towards their QEEG certification requirements. This workshop has been approved by the QEEG Certification Board to provide didactic training which is recognized by the Board toward certification as a technician or a diplomate. This course is based upon the original 24-hour didactic blueprint, that has been in effect in the past. Beginning in 2019, the didactic requirement has increased to 36 hours, by the addition of 12 additional hours. This course remains as originally designed, with the original 24hour content. The following description includes material from the QEEG board certification requirements for the original 24-hour didactic program. Workshop topics will include Editing raw EEG and recognizing and removing or accounting for artifacts. Drug Effects including how drugs affect the EEG patterns, as well as how EEG can be used to predict and monitor drug response. Database Analysis Clinical and Cognitive Aspects , Montages and Spectral and Topographic Aspects of the EEG. Attendees will learn the subject inclusion and exclusion criteria for building a database .and fundamental statistical considerations within databases. Further detailed topics will include the effects of various drugs on the EEG/QEEG data and developmental changes in the EEG and knowledge. Brodmann area functions and network connections will provide an understanding of LORETA and sLORETA interpretation and training Practical information will include knowing which EEG signatures should be referred out to other professionals Be knowledgeable about general cognitive and clinical changes that take effect after neurofeedback training. The remaining required hours are 4 hours of Ethics, and 4 hours of QEEG and Neurofeedback. These can be earned through other classroom or online opportunities that are available and will be briefly described on the first day of this course.

For the past 30 years operant conditioning approaches have largely utilized EEG neurofeedback as a method for regulating the brain. The research shows that EEG neurofeedback has had a positive impact on multiple patient populations, but can take a long time in order to achieve a treatment effect. Neurostimulation approaches have been shown in the research to have a positive impact on multiple patient populations, but the long term effects have not been consistent or enduring. In this workshop Dr. Dogris & Dr. Thompson will demonstrate how to use QEEG data to generate treatment plans and strategies for using pEMF, tDCS, tACS and tRNS stimulation modalities for the treatment of ADHD, Depression, Anxiety, TBI and other clinical diagnosis. Furthermore, a discussion about how pEMF, tDCS, tRNS and tACS can be utilized to address power, coherence and phase dynamics in the EEG. QEEG data will be presented along with clinical outcome data. . . . . . . . . . . ......................................................................... .......... . . . . . . . . . . . . . .. .......................................................................................... .. . . . . .c . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ./ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .